Log In
Print
BCIQ
Print
Print this Print this
 

Viaskin Peanut (DBV-712)

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies S.A.
DescriptionPeanut proteins epicutaneously delivered by Viaskin patch technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat peanut allergy
Regulatory Designation

U.S. - Fast Track (Treat peanut allergy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today